Literature DB >> 24508881

Synthesis, structure, spectral, thermal and first-order molecular hyperpolarizability of 4-benzoylpyridine isonicotinyl hydrazone monohydrate single crystals.

V Meenatchi1, K Muthu1, M Rajasekar1, S P Meenakshisundaram2.   

Abstract

Single crystals of 4-benzoylpyridine isonicotinyl hydrazone monohydrate were grown by slow evaporation solution growth technique from ethanol at room temperature. It belongs to triclinic system with space group P1¯ and the cell parameters are, a=8.9250(2) Å, b=9.1540(2) Å, c=10.87500(10) Å and V=797.88(3) Å(3). Powder XRD closely resembles with that of simulated pattern from single crystal XRD. The characteristic functional groups present in the molecule are confirmed by FT-IR and FT-Raman analyses. The crystal is transparent in the visible region having a lower optical cut-off at ∼420 nm and the band gap energies are estimated by the application of Kubelka-Munk algorithm. Thermal analysis by TG/DTA indicates the stability of the material. The scanning electron microscopy studies reveal the surface morphology of the as-grown crystal. Mass spectrometry provides information pertaining to the structure and molecular weight of the compound. Theoretical calculations were performed using Hartree-Fock method with 6-31G(d,p) as the basis set for to derive the optimized geometry, dipole moment and first-order molecular hyperpolarizality (β) values.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FT-IR and FT-Raman; Mass spectrometry; Optical properties; Organic compounds; Theoretical calculation

Mesh:

Substances:

Year:  2014        PMID: 24508881     DOI: 10.1016/j.saa.2014.01.051

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Chains or rings? Polymorphism of an isoniazid derivative derivatized with diacetone alcohol.

Authors:  Matthew C Scheepers; Manuel A Fernandes; Andreas Lemmerer
Journal:  RSC Adv       Date:  2022-04-14       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.